About: covid:3737b95ec3c0a2fefaa7aafb11de1a899c2505b0

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:3737b95ec3c0a2fefaa7aafb11de1a899c2505b0 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Diaz, Violeta Guevara, Carlos Naves, Rodrigo Rosas, Carlos Villa, Eduardo
is schema:about of	named entity 'Santiago, Chile' named entity 'COVID-19 pandemic' named entity 'COVID-19 pandemic' named entity 'Latin-America' named entity 'quarantine' named entity 'interferons' named entity 'coronavirus' named entity 'respiratory failure' named entity 'COVID' named entity 'Chile' named entity 'lymphocyte count' named entity 'quarantine' named entity 'exposure to the virus' named entity 'natalizumab' named entity 'research ethics committees' named entity 'COVID' named entity '1.6' named entity 'COVID-19 disease' named entity 'health emergencies' named entity 'state of emergency' named entity 'lymphocyte' named entity 'University of Chile' named entity 'infection' named entity 'WHO' named entity 'DMTs' named entity 'DMTs' named entity 'alemtuzumab' named entity 'immunological' named entity 'ocrelizumab' named entity 'acute phase' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'interferon β' named entity 'ocrelizumab' named entity 'cytokine storm syndrome' named entity 'DMTs' named entity 'Italy' named entity 'immunosuppression' named entity 'COVID' named entity 'ocrelizumab' named entity 'interferons' named entity 'DMT' named entity 'alemtuzumab' named entity 'DMTs' named entity 'inflammatory cytokines' named entity 'state of emergency' named entity 'immunosuppressive' named entity 'cladribine' named entity 'primary progressive multiple sclerosis' named entity 'relapsing remitting multiple sclerosis' named entity 'RRMS' named entity 'DMTs' named entity 'immunodeficiency' named entity 'rituximab' named entity 'DMTs' named entity 'DMT' named entity 'DMT' named entity 'COVID-19 disease' named entity 'viral diseases' named entity 'quarantine' named entity 'Expanded Disability Status Scale' named entity 'vaccines' named entity 'ocrelizumab' named entity 'COVID-19 pandemic' named entity 'PPMS' named entity 'alemtuzumab' named entity 'fingolimod' named entity 'EDSS' named entity 'Santiago, Chile' named entity 'Chile' named entity 'Santiago of Chile' named entity 'natalizumab' named entity 'infection' named entity 'University of Chile' named entity 'glatiramer acetate' named entity 'fingolimod' named entity 'Chile' named entity 'quarantine' named entity 'lymphocyte' named entity 'teriflunomide' named entity 'glatiramer acetate' named entity 'COVID-19 pandemic' named entity 'European Centre for Disease Prevention and Control' named entity 'Association of British Neurologists' named entity 'COVID-19 pandemic' named entity 'Multiple Sclerosis' named entity 'sample size' named entity 'neurologists' named entity 'state of emergency' named entity 'COVID' named entity 'contagious disease' named entity 'infection' named entity 'DMTs' named entity 'COVID' named entity 'Ministry of Health of Chile'

Attributes

Values

Creator

Diaz, Violeta
Guevara, Carlos
Naves, Rodrigo
Rosas, Carlos
Villa, Eduardo

is schema:about of

named entity 'Santiago, Chile'
named entity 'COVID-19 pandemic'
named entity 'COVID-19 pandemic'
named entity 'Latin-America'
named entity 'quarantine'
named entity 'interferons'
named entity 'coronavirus'
named entity 'respiratory failure'
named entity 'COVID'
named entity 'Chile'
named entity 'lymphocyte count'
named entity 'quarantine'
named entity 'exposure to the virus'
named entity 'natalizumab'
named entity 'research ethics committees'
named entity 'COVID'
named entity '1.6'
named entity 'COVID-19 disease'
named entity 'health emergencies'
named entity 'state of emergency'
named entity 'lymphocyte'
named entity 'University of Chile'
named entity 'infection'
named entity 'WHO'
named entity 'DMTs'
named entity 'DMTs'
named entity 'alemtuzumab'
named entity 'immunological'
named entity 'ocrelizumab'
named entity 'acute phase'
named entity 'SARS-CoV-2'
named entity 'COVID'
named entity 'interferon β'
named entity 'ocrelizumab'
named entity 'cytokine storm syndrome'
named entity 'DMTs'
named entity 'Italy'
named entity 'immunosuppression'
named entity 'COVID'
named entity 'ocrelizumab'
named entity 'interferons'
named entity 'DMT'
named entity 'alemtuzumab'
named entity 'DMTs'
named entity 'inflammatory cytokines'
named entity 'state of emergency'
named entity 'immunosuppressive'
named entity 'cladribine'
named entity 'primary progressive multiple sclerosis'
named entity 'relapsing remitting multiple sclerosis'
named entity 'RRMS'
named entity 'DMTs'
named entity 'immunodeficiency'
named entity 'rituximab'
named entity 'DMTs'
named entity 'DMT'
named entity 'DMT'
named entity 'COVID-19 disease'
named entity 'viral diseases'
named entity 'quarantine'
named entity 'Expanded Disability Status Scale'
named entity 'vaccines'
named entity 'ocrelizumab'
named entity 'COVID-19 pandemic'
named entity 'PPMS'
named entity 'alemtuzumab'
named entity 'fingolimod'
named entity 'EDSS'
named entity 'Santiago, Chile'
named entity 'Chile'
named entity 'Santiago of Chile'
named entity 'natalizumab'
named entity 'infection'
named entity 'University of Chile'
named entity 'glatiramer acetate'
named entity 'fingolimod'
named entity 'Chile'
named entity 'quarantine'
named entity 'lymphocyte'
named entity 'teriflunomide'
named entity 'glatiramer acetate'
named entity 'COVID-19 pandemic'
named entity 'European Centre for Disease Prevention and Control'
named entity 'Association of British Neurologists'
named entity 'COVID-19 pandemic'
named entity 'Multiple Sclerosis'
named entity 'sample size'
named entity 'neurologists'
named entity 'state of emergency'
named entity 'COVID'
named entity 'contagious disease'
named entity 'infection'
named entity 'DMTs'
named entity 'COVID'
named entity 'Ministry of Health of Chile'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software